These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35402807)

  • 1. Novel chimeric antigen receptor T cells based on T-cell receptor-like antibodies.
    Zhao Q
    Blood Sci; 2019 Oct; 1(2):144-147. PubMed ID: 35402807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TCR-Like CAR-T Cells Targeting MHC-Bound Minor Histocompatibility Antigens.
    Akatsuka Y
    Front Immunol; 2020; 11():257. PubMed ID: 32184779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional comparison of engineered T cells carrying a native TCR versus TCR-like antibody-based chimeric antigen receptors indicates affinity/avidity thresholds.
    Oren R; Hod-Marco M; Haus-Cohen M; Thomas S; Blat D; Duvshani N; Denkberg G; Elbaz Y; Benchetrit F; Eshhar Z; Stauss H; Reiter Y
    J Immunol; 2014 Dec; 193(11):5733-43. PubMed ID: 25362181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins.
    Jost C; Darowski D; Challier J; Pulko V; Hanisch LJ; Xu W; Mössner E; Bujotzek A; Klostermann S; Umana P; Kontermann RE; Klein C
    MAbs; 2020; 12(1):1840709. PubMed ID: 33136521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
    Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
    Front Immunol; 2021; 12():686439. PubMed ID: 34616392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of chimeric antigen receptor of humanized rabbit-derived T cell receptor-like antibody.
    Nakamura T; Kobayashi E; Hamana H; Hayakawa Y; Muraguchi A; Hayashi A; Ozawa T; Kishi H
    Cancer Sci; 2022 Oct; 113(10):3321-3329. PubMed ID: 35766417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic engineering of T cell specificity for immunotherapy of cancer.
    Willemsen RA; Debets R; Chames P; Bolhuis RL
    Hum Immunol; 2003 Jan; 64(1):56-68. PubMed ID: 12507815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting cancers through TCR-peptide/MHC interactions.
    He Q; Jiang X; Zhou X; Weng J
    J Hematol Oncol; 2019 Dec; 12(1):139. PubMed ID: 31852498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells.
    Ma Q; Garber HR; Lu S; He H; Tallis E; Ding X; Sergeeva A; Wood MS; Dotti G; Salvado B; Ruisaard K; Clise-Dwyer K; John LS; Rezvani K; Alatrash G; Shpall EJ; Molldrem JJ
    Cytotherapy; 2016 Aug; 18(8):985-994. PubMed ID: 27265873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting CAR to the Peptide-MHC Complex Reveals Distinct Signaling Compared to That of TCR in a Jurkat T Cell Model.
    Wu L; Brzostek J; Sankaran S; Wei Q; Yap J; Tan TYY; Lai J; MacAry PA; Gascoigne NRJ
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33670734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Peptide-MHC Targeted Chimeric Antigen Receptor T Cell Forms a T Cell-like Immune Synapse.
    Wang SS; Luong K; Gracey FM; Jabar S; McColl B; Cross RS; Jenkins MR
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor.
    Zhang G; Wang L; Cui H; Wang X; Zhang G; Ma J; Han H; He W; Wang W; Zhao Y; Liu C; Sun M; Gao B
    Sci Rep; 2014 Jan; 4():3571. PubMed ID: 24389689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational development of high-affinity T-cell receptor-like antibodies.
    Stewart-Jones G; Wadle A; Hombach A; Shenderov E; Held G; Fischer E; Kleber S; Nuber N; Stenner-Liewen F; Bauer S; McMichael A; Knuth A; Abken H; Hombach AA; Cerundolo V; Jones EY; Renner C
    Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5784-8. PubMed ID: 19307587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging immunotherapeutics in adenocarcinomas: A focus on CAR-T cells.
    Yazdanifar M; Zhou R; Mukherjee P
    Curr Trends Immunol; 2016; 17():95-115. PubMed ID: 28659689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A TCR-based Chimeric Antigen Receptor.
    Walseng E; Köksal H; Sektioglu IM; Fåne A; Skorstad G; Kvalheim G; Gaudernack G; Inderberg EM; Wälchli S
    Sci Rep; 2017 Sep; 7(1):10713. PubMed ID: 28878363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy.
    Zhu L; Yang X; Zhong D; Xie S; Shi W; Li Y; Hou X; HuaYao ; Zhou H; Zhao M; Ding Z; Zhao X; Mo F; Yin S; Liu A; Lu X
    J Immunol Res; 2020; 2020():2454907. PubMed ID: 32964055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chimeric STAR receptors using TCR machinery mediate robust responses against solid tumors.
    Liu Y; Liu G; Wang J; Zheng ZY; Jia L; Rui W; Huang D; Zhou ZX; Zhou L; Wu X; Lin S; Zhao X; Lin X
    Sci Transl Med; 2021 Mar; 13(586):. PubMed ID: 33762437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a T-cell receptor mimic antibody targeting a novel Wilms tumor 1-derived peptide and analysis of its specificity.
    Kurosawa N; Midorikawa A; Ida K; Fudaba YW; Isobe M
    Cancer Sci; 2020 Oct; 111(10):3516-3526. PubMed ID: 32770595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.
    Pietra G; Romagnani C; Falco M; Vitale M; Castriconi R; Pende D; Millo E; Anfossi S; Biassoni R; Moretta L; Mingari MC
    Eur J Immunol; 2001 Dec; 31(12):3687-93. PubMed ID: 11745389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A CD22-reactive TCR from the T-cell allorepertoire for the treatment of acute lymphoblastic leukemia by TCR gene transfer.
    Jahn L; Hagedoorn RS; van der Steen DM; Hombrink P; Kester MG; Schoonakker MP; de Ridder D; van Veelen PA; Falkenburg JH; Heemskerk MH
    Oncotarget; 2016 Nov; 7(44):71536-71547. PubMed ID: 27689397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.